Smoking Cessation Aids Market Global Analysis & Forecast 2028
Si prevede che il mercato degli aiuti per smettere di fumare raggiungerà i 64.032,30 milioni di dollari entro il 2028 dai 23.413,08 milioni di dollari del 2021. Si stima che il mercato crescerà con un CAGR del 15,5% dal 2021 al 2028.
I fattori chiave che stanno guidando la crescita di questo mercato degli aiuti per smettere di fumare sono la crescente dipendenza dal fumo di tabacco, l’aumento del numero di campagne per ridurre la dipendenza dal fumo e dal tabacco. Tuttavia, l’aumento dei costi per lo sviluppo di terapie sostitutive della nicotina frenerà in una certa misura la crescita del mercato negli anni futuri.
Approfondimenti di mercato
Crescente dipendenza dal fumo di tabacco
La nicotina è una sostanza che crea dipendenza e si trova nella pianta del tabacco. È dimostrato che il fumo di tabacco è pericoloso in tutte le sue forme poiché può portare a condizioni di salute croniche, malattie prevenibili, morte e disabilità. Secondo l’Organizzazione Mondiale della Sanità (OMS), i disturbi legati al fumo provocano circa 435.000 decessi all’anno negli Stati Uniti, pari a circa 1 su 5 del totale dei decessi nel paese. Secondo i Centri per il controllo e la prevenzione delle malattie (CDC), nel 2018, quasi 40 milioni di adulti negli Stati Uniti hanno fumato sigarette. Inoltre, circa 4,7 milioni di studenti delle scuole medie e superiori hanno utilizzato almeno un prodotto del tabacco e circa 1.600 giovani di età inferiore ai 18 anni negli Stati Uniti hanno fumato la loro prima sigaretta. Ogni anno quasi mezzo milione di pazienti muore a causa di malattie causate dal fumo. Il governo statunitense spende circa 225 miliardi di dollari per le cure mediche destinate a curare i pazienti affetti da patologie legate al fumo negli Stati Uniti. Pertanto, la prevalenza del fumo di tabacco è elevata in vari paesi del mondo.
Personalizza la ricerca in base alle tue esigenze
Possiamo ottimizzare e personalizzare l'analisi e l'ambito che non sono soddisfatti dalle nostre offerte standard. Questa flessibilità ti aiuterà a ottenere le informazioni esatte necessarie per la pianificazione aziendale e il processo decisionale.
Mercato degli aiuti per smettere di fumare: approfondimenti strategici
CAGR (2021 - 2028)15,5%- Dimensione del mercato nel 2021:
23,41 miliardi di dollari - Dimensione del mercato nel 2028:
64,03 miliardi di dollari
Dinamiche di mercato
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Giocatori chiave
- Pfizer Inc.
- GlaxoSmithKline plc.
- I laboratori del dottor Reddy
- Johnson e Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- BUON DIVERTIMENTO
Panoramica regionale
- Nord America
- Europa
- Asia-Pacifico
- America meridionale e centrale
- Medio Oriente e Africa
Segmentazione del mercato
- Terapia sostitutiva della nicotina
- Droghe
- Sigarette elettroniche
- Altri
- Farmacie ospedaliere
- Canale in linea
- Farmacie al dettaglio
- Altri utenti finali
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Lo scenario è simile in diversi paesi europei e asiatici. Grecia, Bulgaria, Francia e Croazia comprendono le popolazioni ad alto consumo di tabacco in Europa. Secondo l’Institute of Health Metrics and Evaluation, il fumo è una dipendenza molto comune in Europa poiché oltre il 20% degli adulti di età superiore ai 15 anni fuma ogni giorno. Inoltre, secondo la World Population Review, i tassi di fumo più elevati si riscontrano nel sud-est asiatico e nei Balcani in Europa. Il WPR suggerisce inoltre che in vari paesi del Sud e Sud-Est asiatico i tassi di fumo tendono ad essere elevati tra gli uomini. Ad esempio, in Indonesia, il tasso di fumo tra gli uomini era del 76,20% nel 2018. Pertanto, il numero crescente di popolazioni fumatrici in tutto il mondo guida la crescita del mercato globale degli aiuti per smettere di fumare.
Approfondimenti basati sul prodotto
In base al prodotto, il mercato degli aiuti per smettere di fumare è segmentato in terapia sostitutiva della nicotina, farmaci, sigarette elettroniche e altri. Le sigarette elettroniche sono considerate un'alternativa salutare alle sigarette di tabacco e si stima che rappresenteranno il segmento in più rapida crescita nel periodo di previsione. Le sigarette elettroniche rappresentano un’alternativa efficace per ridurre le condizioni di salute associate al tabacco, mentre le terapie sostitutive della nicotina funzionano meglio per smettere di fumare. Le sigarette elettroniche rappresentano una potenziale minaccia per le sigarette a base di tabacco. Inoltre, il consumo di sigarette elettroniche è meno dannoso rispetto alle sigarette normali, non c'è fumo e non c'è rischio di fumo passivo, è consentito l'uso anche in luoghi non fumatori, i livelli variabili di nicotina e la disponibilità in vari gusti sono alcuni dei principali fattori trainanti per il mercato delle sigarette elettroniche. inoltre, la crescente popolarità delle sigarette elettroniche , supportata dalla loro caratteristica elettronica, è il fattore principale che contribuisce alla crescente domanda.
Fine degli approfondimenti basati sull'utente
In base all’utente finale, il mercato degli aiuti per smettere di fumare è segmentato in farmacie ospedaliere, canale online, farmacie al dettaglio e altri utenti finali. È probabile che il segmento delle farmacie al dettaglio deterrà la quota maggiore del mercato nel 2021, tuttavia si prevede che il segmento del canale online registrerà il CAGR più elevato del mercato durante il periodo di previsione.
I principali attori come Pfizer Inc.; GlaxoSmithKline plc.; I laboratori del dottor Reddy; Johnson e Johnson Services, Inc.; Cipla Inc.; Perrigo Company plc; Bausch Health Companies Inc.; Glenmark; BUON DIVERTIMENTO; e Juul Labs adottano diverse strategie organiche e inorganiche per migliorare le proprie entrate e la propria posizione di mercato. Ad esempio, nel luglio 2020, i Laboratori del dottor Reddy hanno lanciato le pastiglie da banco Polacrilex alla nicotina nel mercato americano nei dosaggi di 2 mg e 4 mg. Inoltre, nel novembre 2020, Perrigo Company plc ha completato il quarto anno della campagna “Quitting is Better” in collaborazione con l’American Cancer Society (ACS).
Ambito del rapporto sul mercato degli aiuti per smettere di fumare
Attributo del rapporto | Dettagli |
---|---|
Dimensioni del mercato nel 2021 | 23,41 miliardi di dollari |
Dimensioni del mercato entro il 2028 | 64,03 miliardi di dollari |
CAGR globale (2021-2028) | 15,5% |
Dati storici | 2019-2020 |
Periodo di previsione | 2022-2028 |
Segmenti coperti | Per prodotto
|
Regioni e paesi coperti | Nord America
|
Leader di mercato e profili aziendali chiave |
|
- Il PDF di esempio mostra la struttura del contenuto e la natura delle informazioni con analisi qualitative e quantitative.
Mercato degli aiuti per smettere di fumare – per prodotto
- Terapia sostitutiva della nicotina
- Droghe
- Sigarette elettroniche
- Altri
Mercato degli aiuti per smettere di fumare – per utente finale
- Farmacie ospedaliere
- Canale in linea
- Farmacie al dettaglio
- Altri
Mercato degli aiuti per smettere di fumare – per geografia
Nord America
- NOI
- Canada
- Messico
Europa
- Francia
- Germania
- Italia
- UK
- Spagna
- Resto d'Europa
Asia Pacifico (APAC)
- Cina
- India
- Giappone
- Australia
- Corea del Sud
- Resto dell'Asia Pacifico
Medio Oriente e Africa (MEA)
- Sud Africa
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa
Sud e Centro America (SCAM)
- Brasile
- Argentina
- Resto dell'America meridionale e centrale
Profili aziendali
- Pfizer Inc.
- GlaxoSmithKline plc.
- I laboratori del dottor Reddy
- Johnson e Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- BUON DIVERTIMENTO
- Juul Labs
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Smoking Cessation Aids Market majorly consists of the players such as Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy's Laboratories, Johnson and Johnson Services, Inc., Cipla Inc., Perrigo Company plc, Bausch Health Companies Inc., Glenmark, NJOY, Juul Labs among others amongst others.
The US is the largest market for Smoking Cessation Aids at a global level. The market's growth is attributed to the Increasing implementation of various tobacco control programs, high expenditure in healthcare and wellness by the countries in the region and launch of new and innovative products by market players for smoking cessation are some of the factors likely to drive the Smoking Cessation Aids market in the region. According to CDC, in 2017, 14 of every 100 US adults aged 18 years or older (14.0%) currently smoke cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down.
Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the region. For instance, an international collaboration of researchers, led by those from Vanderbilt University in the United States, studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India in Tobacco Smoking and Mortality in Asia, a pooled meta-analysis published by JAMA Network in March 2019. By 2030, it is anticipated that 8.3 million fatalities would be due to smoking. China, India, and Indonesia account for half of the world's male smokers, and Asia is the world's largest tobacco user and production.
The global Smoking Cessation Aids market based on product is segmented into nicotine replacement therapy, drugs, electronic cigarettes, and others. In 2021, the electronic cigarettes segment held the largest share of the market, by product. The electronic cigarettes segment of Smoking Cessation Aids Market is also expected to witness fastest CAGR during 2021 to 2028.The increasing number of campaigns to reduce smoking and tobacco dependence are likely to increase the demand for the above-mentioned products. Therefore, it is expected that market is likely to propel during the forecast period.
The factors that are driving and restraining factors that will affect Smoking Cessation Aids Market in the coming years. Factors such as rising addiction toward tobacco smoking, increasing number of campaigns to reduce smoking and tobacco dependence. However, steeping costs for development of nicotine replacement therapies are likely to restrain the market growth in the future years to some extent.
Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do not. Counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, may be used to help a person quit smoking.
The List of Companies - Smoking Cessation Aids Market
- Pfizer Inc.
- GlaxoSmithKline plc.
- Dr. Reddy's Laboratories
- Johnson and Johnson Services, Inc.
- Cipla Inc.
- Perrigo Company plc
- Bausch Health Companies Inc.
- Glenmark
- NJOY
- Juul Labs
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.